chemoradiotherapy

You have access
Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy
PO-HSU SU, CHIH-CHUNG HSU, SHUN-WEN HSUEH, CHIA-YEN HUNG, KUN-YUN YEH, HUNG-MING WANG, CHANG-HSIEN LU, YU-CHING LIN, JOSEPH TUNG-CHIEH CHANG and WEN-CHI CHOU

Anticancer Research November 2022, 42 (11) 5609-5618; DOI: https://doi.org/10.21873/anticanres.16069
You have access
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) for Patients With Potentially Resectable Esophageal Cancer
MAKOTO SAKAI, MAKOTO SOHDA, SHINTARO UCHIDA, ARISA YAMAGUCHI, TAKAYOSHI WATANABE, HIDEYUKI SAITO, YASUNARI UBUKATA, NOBUHIRO NAKAZAWA, KENGO KURIYAMA, AKIHIKO SANO, HIROOMI OGAWA, TAKEHIKO YOKOBORI, SHIN-EI NODA, TATSUYA OHNO, KEN SHIRABE and HIROSHI SAEKI

Anticancer Research October 2022, 42 (10) 4929-4935; DOI: https://doi.org/10.21873/anticanres.15999
Open Access
A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck Cancer
TIMOTHY D. SMILE, CHANDANA A. REDDY, BRIAN MATIA, CHRISTOPHER W. FLEMING, CHAIM DOMB, JESSICA L. GEIGER, NIKHIL P. JOSHI, NEIL M. WOODY, DEBORAH J. CHUTE, CHRISTOPHER C. GRIFFITH, DAVID J. ADELSTEIN and SHLOMO A. KOYFMAN

Anticancer Research August 2022, 42 (8) 3845-3852; DOI: https://doi.org/10.21873/anticanres.15875
You have access
Clinical Outcome After Esophagectomy or Definitive Chemoradiotherapy in Elderly Patients (≥80 Years) With Esophageal Cancer
MASATAKA SHIMONOSONO, KEN SASAKI, YUSUKE TSURUDA, MASAHIRO NODA, YASUTO UCHIKADO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, SHINICHIRO MORI, HIROSHI KURAHARA, AKIHIRO NAKAJO and TAKAO OHTSUKA

Anticancer Research August 2022, 42 (8) 3953-3961; DOI: https://doi.org/10.21873/anticanres.15890
You have access
Synergistic Benefit of Adoptive T Cells in Combination With Chemoradiotherapy Against Metastatic Prostate Cancer Cells
YUN-CHU SHEN, HUNG-JEN SHIH, CHI-CHIEN LIN, SHENG-HSIEN HUANG, SHENG-CHUAN WU, CHI-HAO HSIAO, SHAO-CHI CHIU, DER-YANG CHO, CHIN-PAO CHANG, YUEH PAN and PING-HSIAO SHIH

Anticancer Research July 2022, 42 (7) 3427-3434; DOI: https://doi.org/10.21873/anticanres.15829
You have access
Strategy Treatment of cT4b Esophageal Squamous Cell Carcinoma Using Docetaxel, Cisplatin, and 5-Fluorouracil
MASANOBU NAKAJIMA, HIROTO MUROI, MAIKO KIKUCHI, TSUKASA KUBO, SHUHEI TAKISE, KEISUKE IHARA, MASATOSHI NAKAGAWA, SHINJI MORITA, TAKATOSHI NAKAMURA, SATORU YAMAGUCHI and KAZUYUKI KOJIMA

Anticancer Research July 2022, 42 (7) 3725-3733; DOI: https://doi.org/10.21873/anticanres.15862
You have access
Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
MANABU EMI, YOICHI HMAI, TORU YOSHIKAWA, RYOSUKE HIROHATA, MANATO OSAWA, MORIHITO OKADA, YUJI MURAKAMI and IKUNO NISHIBUCHI

Anticancer Research May 2022, 42 (5) 2791-2795; DOI: https://doi.org/10.21873/anticanres.15759
You have access
CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer
YUICHI TACHIKAWA, KAZUSHIGE KAWAI, KOSUKE OZAKI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, JUNKO KISHIKAWA, YUICHIRO YOKOYAMA, SHINYA ABE, YUZO NAGAI, HIROYUKI ANZAI, HIROFUMI SONODA and SOICHIRO ISHIHARA

Anticancer Research April 2022, 42 (4) 2033-2043; DOI: https://doi.org/10.21873/anticanres.15684
You have access
High vs. Standard Radiotherapy Dose in Locally Advanced Rectal Adenocarcinoma Patients Treated With Neoadjuvant Long Course Chemoradiotherapy: A Population-based Study
JI-AN LIANG, YU-CHENG KUO, K.S. CLIFFORD CHAO, WILLIAM TZU-LIANG CHEN, TAO-WEI KE, SZU-HSIEN CHOU, CHIA-CHIN LI and CHUN-RU CHIEN

Anticancer Research February 2022, 42 (2) 1143-1150; DOI: https://doi.org/10.21873/anticanres.15578
You have access
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation
RYO TOYA, TAKAHIRO WATAKABE, DAIZO MURAKAMI, TOMOHIKO MATSUYAMA, TETSUO SAITO, YOSHIYUKI FUKUGAWA, KOHEI NISHIMOTO, YORIHISA ORITA and NATSUO OYA

Anticancer Research January 2022, 42 (1) 205-209; DOI: https://doi.org/10.21873/anticanres.15474

Main menu

User menu

Search

chemoradiotherapy

Pages